Dr. Kuley obtained her PhD in infection biology from Wageningen University in the Netherlands. During her PhD she characterized the Dutch Q-fever outbreak strains of Coxiella burnetii bacteria, which led to a better understanding of the host-pathogen interactions and elucidated novel virulence mechanisms of the outbreak strains. After completion of her PhD she joined the Clark lab in June 2017 at the University of Washington in the Department of Immunology. In the Clark lab she investigated the role of B cell activating factor (BAFF) in B cell responses and autoimmunity. In September 2019 Dr. Kuley joined the Giltiay lab at the Department of Rheumatology where she continued her research on BAFF till June 2020. Her research in the Clark and Giltiay labs identified specific BAFF sources and their regulation that promote protective immunity against bacterial and viral pathogens. In addition, the work also identified the contribution of BAFF in the pathogenesis of autoimmune diseases, particularly systemic lupus erythematosus (SLE). In July 2020 she joined the Lood lab in the Department of Rheumatology where she is primarily exploring the clinical utility of neutrophil biomarkers in rheumatic disease, as well as the role of neutrophils in regulating B cell activation as it pertains to SLE.